Donald Sheppard

The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology

Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.

Viral hepatitis, with respect to federal screening guidelines, data collection, harm reduction funding and policy, testing technology, and prevention, testing, and treatment for people under federal jurisdiction.

CCA was established by the federal government in 2005 to provide assessments of evidence on policy priorities important to the Government of Canada and Canadians. CCA's interactions with federal departments and agencies are focused on developing interest in new assessment projects which are typically funded through a program or grant. Assessments are carried out by expert panels and can be on any topic in areas of health, environment, energy and society, or S&T and innovation.